Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

Benefits and risks of ankylosing spondylitis treatment with nonsteroidal antiinflammatory drugs.

Song IH, Poddubnyy DA, Rudwaleit M, Sieper J.

Arthritis Rheum. 2008 Apr;58(4):929-38. doi: 10.1002/art.23275. Review. No abstract available.

2.

Update on nonsteriodal anti-inflammatory drugs.

Ardoin SP, Sundy JS.

Curr Opin Rheumatol. 2006 May;18(3):221-6. Review.

PMID:
16582683
3.

Methodology issues in the evaluation of NSAID in inflammatory rheumatic diseases.

Lequesne M.

J Rheumatol Suppl. 1990 Feb;20:25-8. Review.

PMID:
2182853
4.

Issues in the treatment of ankylosing spondylitis with non-steroidal anti-inflammatory drugs.

van der Linden S.

Wien Med Wochenschr. 2008;158(7-8):195-9. doi: 10.1007/s10354-008-0521-3. Review.

PMID:
18500470
5.

The safety of celecoxib in ankylosing spondylitis treatment.

Poddubnyy DA, Song IH, Sieper J.

Expert Opin Drug Saf. 2008 Jul;7(4):401-9. doi: 10.1517/14740338.7.4.401 . Review.

PMID:
18613804
6.

Are there any antirheumatic drugs that modify the course of ankylosing spondylitis?

Laurent R.

Baillieres Clin Rheumatol. 1990 Aug;4(2):387-400. Review. No abstract available.

PMID:
1674450
7.
8.

Bisphosphonates as anti-inflammatory agents in ankylosing spondylitis and spondylarthropathies.

Toussirot E, Wendling D.

Expert Opin Pharmacother. 2005 Jan;6(1):35-43. Review.

PMID:
15709881
9.

Therapeutic usage of the non-steroidal anti-inflammatory drugs.

Champion GD.

Med J Aust. 1988 Aug 15;149(4):203, 206-10, 212-3. Review. No abstract available.

PMID:
3050393
10.

Antiinflammatory treatment with bisphosphonates in ankylosing spondylitis.

Toussirot E, Wendling D.

Curr Opin Rheumatol. 2007 Jul;19(4):340-5. Review.

PMID:
17551363
11.

Nonsteroidal antiinflammatory drugs and reproduction.

Dawood MY.

Am J Obstet Gynecol. 1993 Nov;169(5):1255-65. Review.

PMID:
8238194
12.

Nonsteroidal antiinflammatory drugs in menorrhagia.

Duncan KM, Hart LL.

Ann Pharmacother. 1993 Nov;27(11):1353-5. Review. No abstract available.

PMID:
8286809
13.

Tumour necrosis factor inhibitors in ankylosing spondylitis.

Reed MR, Taylor AL.

Intern Med J. 2008 Oct;38(10):781-9. doi: 10.1111/j.1445-5994.2008.01639.x. Epub 2008 Apr 14. Review.

PMID:
18422565
14.

Can structural damage be prevented in ankylosing spondylitis?

Sieper J.

Curr Opin Rheumatol. 2009 Jul;21(4):335-9. doi: 10.1097/BOR.0b013e32832c668a. Review.

PMID:
19424070
15.

Multiple indomethacin-induced jejunal ulcerations with perforation: a case report with histology.

Risty GM, Najarian MM, Shapiro SB.

Am Surg. 2007 Apr;73(4):344-6. Review.

PMID:
17439025
16.

Evaluating non-steroidal antiinflammatory drugs.

Husby G.

Scand J Rheumatol. 1988;17(1):3-10. Review. No abstract available.

PMID:
3285452
17.
18.

[Value of various signs as diagnostic criteria of spondylarthropathies].

Amor B.

Z Rheumatol. 1994 Jul-Aug;53(4):230-3. Review. German. No abstract available.

PMID:
7975934
19.

Therapy for the seronegative spondyloarthropathies.

Buxbaum J.

Curr Opin Rheumatol. 1992 Aug;4(4):500-6. Review.

PMID:
1503873
20.

Nonsteroidal anti-inflammatory drugs. Balancing benefits and risks.

Saag KG, Cowdery JS.

Spine (Phila Pa 1976). 1994 Jul 1;19(13):1530-4. Review. No abstract available.

PMID:
7939988

Supplemental Content

Support Center